Literature DB >> 30698015

Metabolomics Analyses of 14 Classical Neurotransmitters by GC-TOF with LC-MS Illustrates Secretion of 9 Cell-Cell Signaling Molecules from Sympathoadrenal Chromaffin Cells in the Presence of Lithium.

Vivian Hook1,2, Tobias Kind3, Sonia Podvin1, Mine Palazoglu3, Carol Tran3, Thomas Toneff1, Stephanie Samra3, Christopher Lietz1, Oliver Fiehn3.   

Abstract

The classical small molecule neurotransmitters are essential for cell-cell signaling in the nervous system for regulation of behaviors and physiological functions. Metabolomics approaches are ideal for quantitative analyses of neurotransmitter profiles but have not yet been achieved for the repertoire of 14 classical neurotransmitters. Therefore, this study developed targeted metabolomics analyses by full scan gas chromatography/time-of-flight mass spectrometry (GC-TOF) and hydrophilic interaction chromatography-QTRAP mass spectrometry (HILIC-MS/MS) operated in positive ionization mode for identification and quantitation of 14 neurotransmitters consisting of acetylcholine, adenosine, anandamide, aspartate, dopamine, epinephrine, GABA, glutamate, glycine, histamine, melatonin, norepinephrine, serine, and serotonin. GC-TOF represents a new metabolomics method for neurotransmitter analyses. Sensitive measurements of 11 neurotransmitters were achieved by GC-TOF, and three neurotransmitters were analyzed by LC-MS/MS (acetylcholine, anandamide, and melatonin). The limits of detection (LOD) and limits of quantitation (LOQ) were assessed for linearity for GC-TOF and LC-MS/MS protocols. In neurotransmitter-containing dense core secretory vesicles of adrenal medulla, known as chromaffin granules (CG), metabolomics measured the concentrations of 9 neurotransmitters consisting of the catecholamines dopamine, norepinephrine, and epinephrine, combined with glutamate, serotonin, adenosine, aspartate, glycine, and serine. The CG neurotransmitters were constitutively secreted from sympathoadrenal chromaffin cells in culture. Nicotine- and KCl-stimulated release of the catecholamines and adenosine. Lithium, a drug used for the treatment of bipolar disorder, decreased the constitutive secretion of dopamine and norepinephrine and decreased nicotine-stimulated secretion of epinephrine. Lithium had no effect on other secreted neurotransmitters. Overall, the newly developed GC-TOF with LC-MS/MS metabolomics methods for analyses of 14 neurotransmitters will benefit investigations of neurotransmitter regulation in biological systems and in human disease conditions related to drug treatments.

Entities:  

Keywords:  adrenal medulla; classical neurotransmitters; lithium; mass spectrometry; metabolomics; secretion

Mesh:

Substances:

Year:  2019        PMID: 30698015      PMCID: PMC7328367          DOI: 10.1021/acschemneuro.8b00432

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  76 in total

Review 1.  Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.

Authors:  Jorge A Quiroz; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Neuropsychobiology       Date:  2010-05-07       Impact factor: 2.328

2.  Detection of 28 neurotransmitters and related compounds in biological fluids by liquid chromatography/tandem mass spectrometry.

Authors:  Sophie Bourcier; Jean-François Benoist; Frédéric Clerc; Odile Rigal; Méryam Taghi; Yannik Hoppilliard
Journal:  Rapid Commun Mass Spectrom       Date:  2006       Impact factor: 2.419

3.  Metabolite profiling in blood plasma.

Authors:  Oliver Fiehn; Tobias Kind
Journal:  Methods Mol Biol       Date:  2007

4.  The adrenal chromaffin cell.

Authors:  S W Carmichael; H Winkler
Journal:  Sci Am       Date:  1985-08       Impact factor: 2.142

5.  A novel action of lithium: stimulation of glutamate release and inositol 1,4,5 trisphosphate accumulation via activation of the N-methyl D-aspartate receptor in monkey and mouse cerebral cortex slices.

Authors:  L E Hokin; J F Dixon; G V Los
Journal:  Adv Enzyme Regul       Date:  1996

6.  Profiles of secreted neuropeptides and catecholamines illustrate similarities and differences in response to stimulation by distinct secretagogues.

Authors:  Sonia Podvin; Richard Bundey; Thomas Toneff; Michael Ziegler; Vivian Hook
Journal:  Mol Cell Neurosci       Date:  2015-06-16       Impact factor: 4.314

7.  Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Adam L Halberstadt; Xiaoxi Zhuang; Jared W Young
Journal:  J Affect Disord       Date:  2013-11-16       Impact factor: 4.839

8.  High plasma norepinephrine levels in patients with major affective disorder.

Authors:  C R Lake; D Pickar; M G Ziegler; S Lipper; S Slater; D L Murphy
Journal:  Am J Psychiatry       Date:  1982-10       Impact factor: 18.112

9.  Metabolomics of Neurotransmitters and Related Metabolites in Post-Mortem Tissue from the Dorsal and Ventral Striatum of Alcoholic Human Brain.

Authors:  Mohammed Abul Kashem; Selina Ahmed; Nilufa Sultana; Eakhlas U Ahmed; Russell Pickford; Caroline Rae; Omar Šerý; Iain S McGregor; Vladimir J Balcar
Journal:  Neurochem Res       Date:  2016-01-22       Impact factor: 3.996

10.  Advances in structure elucidation of small molecules using mass spectrometry.

Authors:  Tobias Kind; Oliver Fiehn
Journal:  Bioanal Rev       Date:  2010-08-21
View more
  2 in total

1.  SS-31 does not prevent or reduce muscle atrophy 7 days after a 65 kdyne contusion spinal cord injury in young male mice.

Authors:  Zachary A Graham; Jennifer J DeBerry; Christopher P Cardozo; Marcas M Bamman
Journal:  Physiol Rep       Date:  2022-05

2.  Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer's Disease Brain.

Authors:  Sonia Podvin; Zhenze Jiang; Ben Boyarko; Leigh-Ana Rossitto; Anthony O'Donoghue; Robert A Rissman; Vivian Hook
Journal:  ACS Chem Neurosci       Date:  2022-06-27       Impact factor: 5.780

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.